🇺🇸 FDA
Patent

US 8980887

2-aryl imidazo[1,2-a]pyridine-3-acetamide derivatives, preparation methods and uses thereof

granted A61PA61P25/00A61P25/04

Quick answer

US patent 8980887 (2-aryl imidazo[1,2-a]pyridine-3-acetamide derivatives, preparation methods and uses thereof) held by Toxicology Academy of Military Medical Sciences P.L.A., China expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Toxicology Academy of Military Medical Sciences P.L.A., China
Grant date
Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P25/00, A61P25/04, A61P25/08, A61P25/18